Cargando…
Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
[Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655762/ https://www.ncbi.nlm.nih.gov/pubmed/34901600 http://dx.doi.org/10.1021/acsomega.1c03990 |
_version_ | 1784612139031330816 |
---|---|
author | Zhang, Jian Zheng, Ying-Ying Wu, Ting-Ting Ma, Xiang Ma, Yi-Tong Xie, Xiang Tang, Bao-Peng |
author_facet | Zhang, Jian Zheng, Ying-Ying Wu, Ting-Ting Ma, Xiang Ma, Yi-Tong Xie, Xiang Tang, Bao-Peng |
author_sort | Zhang, Jian |
collection | PubMed |
description | [Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients with CAD after PCI enrolled in CORFCHD-PCI from January 2008 to December 2016. We divided these patients into two groups according to diabetes (diabetic group, n = 3809, and nondiabetic group, n = 2240). During a follow-up time of 35.9 ± 22.6 months, we compared the incidences of all-cause mortality (ACM) and cardiac mortality (CM), which were assigned as the primary outcomes between patients with a high BRTP score (≥5 points) and those with a low BRTP score (<5 points). Results: We found that the BRTP score independently predicted the risk for ACM and CM in both diabetic patients [ACM, hazard risk (HR) = 1.748 (95% confidence interval (CI): 1.186–2.575), P = 0.005; CM, HR = 1.728 (95% CI: 1.120–2.667), P = 0.014] and nondiabetic patients [ACM, HR = 1.682 (95% CI: 1.208–2.340), P = 0.002; CM, HR = 1.718 (95% CI: 1.188–2.484), P = 0.004]. However, the BRTP score was found to be an independent predictor for major adverse cardiovascular event (MACE) and major adverse cardiovascular and cerebrovascular event (MACCE) in diabetic patients [MACE, HR = 1.366 (95% CI: 1.076–1.734), P = 0.010; MACCE, HR = 1.330 (95% CI: 1.035–1.710), P = 0.026] but not in nondiabetic patients [MACE, HR = 1.241 (95% CI: 0.994–1.549), P = 0.056; MACCE, HR = 1.238 (95% CI: 0.981–1.562), P = 0.072]. Conclusions: This study suggests that the BRTP score is an independent and novel predictor of mortality in CAD patients who had undergone PCI, especially in patients with comorbidity of diabetes. Trial registration: ChiCTR-ROC-16010153. Registered 14, December, 2016. |
format | Online Article Text |
id | pubmed-8655762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-86557622021-12-10 Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study Zhang, Jian Zheng, Ying-Ying Wu, Ting-Ting Ma, Xiang Ma, Yi-Tong Xie, Xiang Tang, Bao-Peng ACS Omega [Image: see text] Background: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI). Methods: There were 6049 patients with CAD after PCI enrolled in CORFCHD-PCI from January 2008 to December 2016. We divided these patients into two groups according to diabetes (diabetic group, n = 3809, and nondiabetic group, n = 2240). During a follow-up time of 35.9 ± 22.6 months, we compared the incidences of all-cause mortality (ACM) and cardiac mortality (CM), which were assigned as the primary outcomes between patients with a high BRTP score (≥5 points) and those with a low BRTP score (<5 points). Results: We found that the BRTP score independently predicted the risk for ACM and CM in both diabetic patients [ACM, hazard risk (HR) = 1.748 (95% confidence interval (CI): 1.186–2.575), P = 0.005; CM, HR = 1.728 (95% CI: 1.120–2.667), P = 0.014] and nondiabetic patients [ACM, HR = 1.682 (95% CI: 1.208–2.340), P = 0.002; CM, HR = 1.718 (95% CI: 1.188–2.484), P = 0.004]. However, the BRTP score was found to be an independent predictor for major adverse cardiovascular event (MACE) and major adverse cardiovascular and cerebrovascular event (MACCE) in diabetic patients [MACE, HR = 1.366 (95% CI: 1.076–1.734), P = 0.010; MACCE, HR = 1.330 (95% CI: 1.035–1.710), P = 0.026] but not in nondiabetic patients [MACE, HR = 1.241 (95% CI: 0.994–1.549), P = 0.056; MACCE, HR = 1.238 (95% CI: 0.981–1.562), P = 0.072]. Conclusions: This study suggests that the BRTP score is an independent and novel predictor of mortality in CAD patients who had undergone PCI, especially in patients with comorbidity of diabetes. Trial registration: ChiCTR-ROC-16010153. Registered 14, December, 2016. American Chemical Society 2021-11-29 /pmc/articles/PMC8655762/ /pubmed/34901600 http://dx.doi.org/10.1021/acsomega.1c03990 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Zhang, Jian Zheng, Ying-Ying Wu, Ting-Ting Ma, Xiang Ma, Yi-Tong Xie, Xiang Tang, Bao-Peng Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study |
title | Blood Routine Test Parameters Score, a Novel Predictor
of Adverse Outcomes of Coronary Artery Disease Patients with or without
Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective
Cohort Study |
title_full | Blood Routine Test Parameters Score, a Novel Predictor
of Adverse Outcomes of Coronary Artery Disease Patients with or without
Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective
Cohort Study |
title_fullStr | Blood Routine Test Parameters Score, a Novel Predictor
of Adverse Outcomes of Coronary Artery Disease Patients with or without
Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective
Cohort Study |
title_full_unstemmed | Blood Routine Test Parameters Score, a Novel Predictor
of Adverse Outcomes of Coronary Artery Disease Patients with or without
Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective
Cohort Study |
title_short | Blood Routine Test Parameters Score, a Novel Predictor
of Adverse Outcomes of Coronary Artery Disease Patients with or without
Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective
Cohort Study |
title_sort | blood routine test parameters score, a novel predictor
of adverse outcomes of coronary artery disease patients with or without
diabetes who underwent percutaneous coronary intervention: a retrospective
cohort study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655762/ https://www.ncbi.nlm.nih.gov/pubmed/34901600 http://dx.doi.org/10.1021/acsomega.1c03990 |
work_keys_str_mv | AT zhangjian bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT zhengyingying bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT wutingting bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT maxiang bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT mayitong bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT xiexiang bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy AT tangbaopeng bloodroutinetestparametersscoreanovelpredictorofadverseoutcomesofcoronaryarterydiseasepatientswithorwithoutdiabeteswhounderwentpercutaneouscoronaryinterventionaretrospectivecohortstudy |